CAPITOL HILL CONSULTING GROUP

Lobbying for BYHEART, INC. · Infant Formulat Manufacturer

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $50,000.00 income · posted Apr 21, 2026

Lobbying activity 3

Health Issues

Infant Formula Safety, Nutrition, Innovation, and Manufacturing.

Food Industry (safety, labeling, etc.)

Infant Formula Safety, Nutrition, Innovation, and Manufacturing.

Manufacturing

Infant Formula Safety, Nutrition, Innovation, and Manufacturing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.